Chemoinformaics analysis of Acetylcephalotaxine
| Molecular Weight | 357.406 | nRot | 2 |
| Heavy Atom Molecular Weight | 334.222 | nRig | 25 |
| Exact Molecular Weight | 357.158 | nRing | 5 |
| Solubility: LogS | -3.943 | nHRing | 3 |
| Solubility: LogP | 2.51 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 6 | APOL | 53.8462 |
| nHD | 0 | BPOL | 32.5958 |
| QED | 0.758 |
| Synth | 4.36 |
| Natural Product Likeliness | 2.261 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.968 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.835 |
| MDCK | 0.0000372 |
| BBB | 0.986 |
| PPB | 0.453079 |
| VDSS | 1.865 |
| FU | 0.459055 |
| CYP1A2-inh | 0.37 |
| CYP1A2-sub | 0.567 |
| CYP2c19-inh | 0.344 |
| CYP2c19-sub | 0.916 |
| CYP2c9-inh | 0.142 |
| CYP2c9-sub | 0.401 |
| CYP2d6-inh | 0.958 |
| CYP2d6-sub | 0.642 |
| CYP3a4-inh | 0.934 |
| CYP3a4-sub | 0.915 |
| CL | 12.474 |
| T12 | 0.158 |
| hERG | 0.399 |
| Ames | 0.563 |
| ROA | 0.777 |
| SkinSen | 0.07 |
| Carcinogencity | 0.9 |
| EI | 0.01 |
| Respiratory | 0.91 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.641703 |